Thermo Fisher Scientific Debt to Equity Ratio 2010-2022 | TMO

Current and historical debt to equity ratio values for Thermo Fisher Scientific (TMO) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Thermo Fisher Scientific debt/equity for the three months ending September 30, 2022 was 0.65.
Thermo Fisher Scientific Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2022-09-30 $46.93B $43.61B 1.08
2022-06-30 $48.23B $42.35B 1.14
2022-03-31 $51.73B $41.02B 1.26
2021-12-31 $54.27B $40.86B 1.33
2021-09-30 $34.89B $38.71B 0.90
2021-06-30 $30.84B $36.85B 0.84
2021-03-31 $30.87B $35.06B 0.88
2020-12-31 $34.54B $34.52B 1.00
2020-09-30 $32.24B $31.82B 1.01
2020-06-30 $31.72B $29.88B 1.06
2020-03-31 $30.13B $28.56B 1.06
2019-12-31 $28.71B $29.68B 0.97
2019-09-30 $27.37B $29.36B 0.93
2019-06-30 $29.24B $28.73B 1.02
2019-03-31 $27.90B $27.69B 1.01
2018-12-31 $28.65B $27.59B 1.04
2018-09-30 $28.19B $26.89B 1.05
2018-06-30 $28.96B $26.45B 1.10
2018-03-31 $30.46B $26.12B 1.17
2017-12-31 $31.26B $25.41B 1.23
2017-09-30 $31.28B $24.70B 1.27
2017-06-30 $24.12B $22.39B 1.08
2017-03-31 $24.42B $21.80B 1.12
2016-12-31 $24.37B $21.54B 1.13
2016-09-30 $26.35B $21.66B 1.22
2016-06-30 $20.99B $21.26B 0.99
2016-03-31 $22.03B $20.92B 1.05
2015-12-31 $19.48B $21.35B 0.91
2015-09-30 $20.30B $20.85B 0.97
2015-06-30 $21.10B $20.68B 1.02
2015-03-31 $21.94B $19.92B 1.10
2014-12-31 $22.30B $20.55B 1.09
2014-09-30 $22.18B $20.51B 1.08
2014-06-30 $23.66B $20.66B 1.15
2014-03-31 $25.70B $20.43B 1.26
2013-12-31 $15.01B $16.86B 0.89
2013-09-30 $11.84B $16.44B 0.72
2013-06-30 $11.83B $15.80B 0.75
2013-03-31 $11.81B $15.60B 0.76
2012-12-31 $11.98B $15.47B 0.78
2012-09-30 $12.29B $15.29B 0.80
2012-06-30 $11.27B $15.09B 0.75
2012-03-31 $11.53B $15.29B 0.75
2011-12-31 $11.80B $15.04B 0.78
2011-09-30 $11.80B $15.20B 0.78
2011-06-30 $8.41B $15.67B 0.54
2011-03-31 $8.18B $15.26B 0.54
2010-12-31 $5.99B $15.36B 0.39
2010-09-30 $6.14B $15.40B 0.40
2010-06-30 $5.94B $15.35B 0.39
2010-03-31 $6.15B $15.48B 0.40
2009-12-31 $6.19B $15.43B 0.40
2009-09-30 $6.02B $15.40B 0.39
2009-06-30 $6.08B $15.08B 0.40
2009-03-31 $6.04B $14.99B 0.40
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $220.806B $39.211B
Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics.
Stock Name Country Market Cap PE Ratio
Edwards Lifesciences (EW) United States $47.328B 32.57
Alcon (ALC) Switzerland $34.365B 29.59
STERIS (STE) Ireland $19.157B 23.84
Teleflex (TFX) United States $11.379B 18.46
Fresenius Medical Care AG KGaA (FMS) Germany $9.600B 9.64
Penumbra (PEN) United States $8.008B 1916.82
Globus Medical (GMED) United States $7.483B 38.05
Integer Holdings (ITGR) United States $2.426B 19.47
Glaukos (GKOS) United States $2.281B 0.00
Nevro (NVRO) United States $1.601B 0.00
Paragon 28 (FNA) United States $1.511B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.261B 17.96
Artivion (AORT) United States $0.546B 0.00